Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors

Phase 2

Recruiting

Conditions: Survivorship

Interventions: Behavioral: Behavioral Activation
Behavioral: Supportive Psychotherapy

First Posted Date: 2022-10-10

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 90

Registration Number: NCT05574127

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Phase 2

Recruiting

Conditions: Metastatic Triple-Negative Breast Cancer
Breast Cancer

Interventions: Drug: Eribulin
Other: Placebo
Drug: SDX-7320

First Posted Date: 2022-10-06

Last Posted Date: 2025-04-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 55

Registration Number: NCT05570253

Locations: 🇺🇸
BAPTIST ALLIANCE - MCI (Data Collection Only), Miami, Florida, United States
🇺🇸
Emory University (Data Collection Only), Atlanta, Georgia, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

and more 7 locations

A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)

Recruiting

Conditions: Colorectal Cancer

First Posted Date: 2022-10-05

Last Posted Date: 2024-12-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 160

Registration Number: NCT05568420

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer

Phase 1

Recruiting

Conditions: Solid Tumor
Metastatic Cancer

Interventions: Drug: RP-3500
Radiation: External Beam Radiotherapy (EBRT)

First Posted Date: 2022-10-04

Last Posted Date: 2025-04-29

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 84

Registration Number: NCT05566574

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center at Suffolk-Commack (All Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States

and more 4 locations

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

Phase 1

Recruiting

Conditions: Bladder Cancer

Interventions: Drug: [68Ga]PSMA
Diagnostic Test: PET/CT imaging

First Posted Date: 2022-10-03

Last Posted Date: 2024-12-31

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 20

Registration Number: NCT05562791

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)

Recruiting

Conditions: Breast Cancer Female
Breast Cancer

Interventions: Procedure: mHealth US-breast biopsy

First Posted Date: 2022-09-30

Last Posted Date: 2025-04-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 900

Registration Number: NCT05561842

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
🇳🇬
Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria
🇳🇬
Olabisis Onabanjo University Teaching Hospital (Data Collection Only), Sagamu, Ogun State, Nigeria

and more 5 locations

Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

Recruiting

Conditions: Metastatic Brain Tumor
Brain Metastases
Brain Metastases, Adult
Metastatic Brain Cancer

Interventions: Diagnostic Test: CEST-MRF

First Posted Date: 2022-09-29

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 119

Registration Number: NCT05559853

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment

Phase 1

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Belantamab Mafodotin
Drug: Nirogacestat
Drug: Pomalidomide

First Posted Date: 2022-09-27

Last Posted Date: 2025-05-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 9

Registration Number: NCT05556798

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

Phase 2

Recruiting

Conditions: Head and Neck Squamous Cell Carcinoma
Head and Neck Cancer
Head and Neck Carcinoma
Head and Neck Neoplasms

Interventions: Diagnostic Test: 18F-FMISO PET/CT scan
Radiation: Chemoradiation therapy
Drug: Carboplatin

First Posted Date: 2022-09-16

Last Posted Date: 2025-05-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT05544136

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 3 locations

A Study of Cognitive Health in Survivors of Prostate Cancer

Active, not recruiting

Conditions: Survivorship
Prostate Cancer

Interventions: Behavioral: PROMIS-SF v2.0 -Cognitive Function 8a

First Posted Date: 2022-09-15

Last Posted Date: 2025-04-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 200

Registration Number: NCT05540782

Locations: 🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center Suffolk - Commack, Commack, New York, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy